Table 1 Baseline characteristics of patients
Parameter | Control Group (n = 132) | Observation Group (n = 49) | X2/t | P |
|---|---|---|---|---|
Male/Female | 74/58 | 30/19 | 0.207 | 0.649 |
Age (Mean ± SD) | 58.52 ± 6.26 | 57.70 ± 7.30 | 1.840 | 0.069 |
BMI (Mean ± SD) | 24.8 ± 3.2 | 24.8 ± 3.2 | -0.320 | 0.749 |
Disease Diagnosis | 0.048 | 0.976 | ||
Pancreatic Cancer | 16.7% (22/132) | 16.3% (8/49) | ||
Liver Cancer | 18.9% (25/132) | 18.4% (9/49) | ||
Colon Cancer | 13.6% (18/132) | 12.2% (6/49) | ||
Bile Duct Cancer | 11.4% (15/132) | 16.3% (8/49) | ||
Stomach Cancer | 15.2% (20/132) | 12.2% (6/49) | ||
Obstructive Jaundice | 16.7% (22/132) | 18.4% (9/49) | ||
Others | 7.58% (10/132) | 6.12% (3/49) | ||
ALT (U/L) | 139.89 ± 3.02 | 139.78 ± 2.98 | -0.220 | 0.826 |
AST (U/L) | 151.80 ± 3.78 | 151.67 ± 3.45 | -0.198 | 0.844 |
TBil (µmol/L) | 328.17 ± 5.16 | 327.37 ± 4.12 | -0.985 | 0.326 |
DBil (µmol/L) | 182.70 ± 10.46 | 181.10 ± 12.27 | -0.873 | 0.384 |